Pinned Tweet
So excited and honoured to be elected to the Young Academy of Sweden! I am very grateful for this opportunity to actively impact research politics and work conditions for young research leaders
Fantastiska forskare från ett brett spektrum av discipliner: 8 nya ledamöter välkomnas till Sveriges unga akademi: sverigesungaakademi.se/nyalm… @umeauniversitet @lunduniversity @uppsalauni @SCAS_Uppsala @goteborgsuni @karolinskainst
It’s that time of the year again! ✨
Registration is now open for the 2026 edition of our course “Biomarkers for neurodegenerative diseases”, this time taking place at the Barcelonaβeta Brain Research Center on June 1-5.
biomarker-course.org
Michael Schöll retweeted
I’m proud to share our systematic review & meta-analysis of plasma p-tau diagnostic accuracy studies :)
thelancet.com/journals/laneu…
Some highlights:
Michael Schöll retweeted
Largest-ever tau-PET studies confirm ties between tangles and cognitive decline. ApoE4 carriers and women get tangles earliest. @_michael_scholl @AlexisMoscoso9 @amsterdamumc ow.ly/k8O750WqRix
Michael Schöll retweeted
NPTX2 is emerging as a key neurodegeneration biomarker, but measurement tools are limited. We developed a low-volume, automated Simoa assay for its quantification in CSF #biomarkers #neurodegeneration
pubmed.ncbi.nlm.nih.gov/4052…
Our most important paper, out now! A massive international collaboration, led by @AlexisMoscoso9, featuring over 6500 visually assessed tau PET scans covering the #Alzheimers spectrum!
Thank you very much to the numerous contributors and collaborators who made this gem possible.
Tau PET positivity is detectable in a small but nonnegligible proportion of individuals in the preclinical stages of #Alzheimer disease, with increasing frequency in symptomatic stages of the disease.
ja.ma/4e29SDX
Michael Schöll retweeted
Tau PET positivity is detectable in a small but nonnegligible proportion of individuals in the preclinical stages of #Alzheimer disease, with increasing frequency in symptomatic stages of the disease.
ja.ma/4e29SDX
Michael Schöll retweeted
'Cautions on utilizing plasma GFAP level as a #biomarker for reactive #astrocytes in #neurodegenerative diseases'
Wongu Youn, Mijin Yun @CJustinLee1 Michael Schöll @_michael_scholl @uniofgothenburg
bit.ly/431DTjH
Michael Schöll retweeted
So excited and honored to be invited to present the opening plenary at #AIC2025 this year in Toronto! 🧠
🙏 I would be very grateful if you could help me gather the most inspiring papers (including your own!) of the past year by completing this survey: alz.surveymonkey.com/r/923BT…
🚨Calling all neuroimagers! Help @EmmaCoomans shape the opening plenary at #AIC2025 (Toronto, July 26th) "Accomplishments of the Past Year" and share the most impactful neuroimaging research from the past year via this brief survey (~5min) by May 30th.
act.alz.org/site/R?i=eOejFv9…
Michael Schöll retweeted
Happy to share our latest work published today in @NatureComms
We leverage #ai enhanced microscopy guided #maldi @imaging_ms to delineate #amyloid plaque polymorphism in #Alzheimers Fantastic collaboration with @_michael_scholl
rdcu.be/ejcHj
@SahlgrenskaAcad @UCLIoN
Michael Schöll retweeted
Why academia is sleepwalking into self-destruction. My editorial @Brain1878 If you agree with the sentiments please RT. It's important for all our sakes to stop the madness
academic.oup.com/brain/issue…
Michael Schöll retweeted
Congratulations to @WillCoath on passing his PhD viva exploring amyloid and tau PET in the Insight 1946 birth cohort! Many thanks to examiners Prof @Hammers_Alexand and @PareshMalhotra and fellow supervisors @_michael_scholl and @jmschott
Michael Schöll retweeted
Ready for the @SahlgrenskaAcad Junior Researcher Symposium, hosted by Future Faculty? Join us at 1 PM for an inspiring keynote by @_michael_scholl ! 🌟 #Research #FutureFaculty #JuniorResearchers
gu.se/en/sahlgrenska-akademi…
Michael Schöll retweeted
Incredibly happy and proud to share our newest work in @ScienceTM showing that Aβ promotes neuronal hyperconnectivity, thereby driving tau spread across connected brain regions. Many thanks to to first authors @SebRoemer and Fabian Wagner!
science.org/doi/10.1126/scit…
Thread below
Always my favourite post at the beginning of the year:
Registration for our course “Biomarkers for neurodegenerative diseases” is now open!
This year’s edition takes place at @UCLIoN in central London on May 12-16.
biomarker-course.org
Happy to share this narrative review paper on the clinical use of blood-based biomarkers for #Alzheimer’s disease, hopefully this can serve as a resource to anyone seeking advice on implementation
#endalz
sciencedirect.com/science/ar…
(in combination with this recent publication: thelancet.com/journals/lanhl…)
Michael Schöll retweeted
We're delighted that 22 of our academics have been identified in Clarivate’s annual ‘Highly Cited Researchers List’ 2024, recognising authors of the most influential research papers around the world.
🔗bit.ly/3ZARQ4R
Third time’s a charm! 🎈
Very honoured to be ranked among the world’s most influential researchers according to Clarivate Web of Science three years in a row now!
Praise belongs to my team, our collaborators and our study participants!
clarivate.com/highly-cited-r…






















